Sanofi-Aventis SpA
Patent Owner
Stats
- 15 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Apr 08, 2014 most recent publication
Details
- 15 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 134 Total Citation Count
- May 19, 1986 Earliest Filing
- 2 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8691773 Peptide compound with biological activity, its preparation and its applicationsOct 06, 08Apr 08, 14[A61K, C07K]
8039006 Solid composition containing bacillus-type non-pathogenic bacterial sporesJul 26, 02Oct 18, 11[A61K, A01N, C12P]
6573366 Process for the purification of human interleukin-1 receptor antagonist from recombinant E. coliMay 09, 00Jun 03, 03[C12P, C07K]
6417350 Preparation of (11.beta.,16.beta.)-21-(3-carboxy-1-oxopropoxy)-11-hydroxy-2'-methyl-5'H-pregna-1,4-dieno [17,16-D]oxazole-3,20-dioneJan 20, 00Jul 09, 02[C07J]
6228851 Process for the purification of 11.beta.-21-dihydroxy-2'-methyl-5'.beta.H-pregna-1,4-dieno[17,16-D]oxazole-3,20-dioneAug 07, 98May 08, 01[A61K, C07J]
6103895 Preparation of (11.beta.,16.beta.)-21-(acetyloxy)-11-hydroxy-2'-methyl-5'H-pregna-1,4-d ieno[17,16-d]oxazole-3,20-dioneJun 05, 98Aug 15, 00[C07J]
5939523 Purification of dalbaheptide antibiotics by isoelectric focusingDec 18, 97Aug 17, 99[A61K, C07K]
5786350 36-derivatives of rifamycins and their use as antimicrobial agentsJan 31, 97Jul 28, 98[C07D, A61D]
Expired/Abandoned/Withdrawn Patents
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
